Brain scan study for early psychosis symptoms
Treatments studied
Part of Mental health clinical trials.
This study uses brain imaging to look at dopamine activity in people at high risk for psychosis. The results may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 30 years old.
- You must not have taken antipsychotic medication for at least 3 weeks before the scan.
- You must be considered at clinical high risk for psychosis (e.g., based on certain interviews or assessments).
- You must be clinically stable and able to give informed consent.
- You cannot have a substance use disorder (other than nicotine or caffeine) in the past month, and you cannot use drugs (other than marijuana, nicotine, or caffeine) on the day of the scan.
- You cannot be pregnant, breastfeeding, have insulin-dependent diabetes, or have certain medical conditions like heart disease or high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called MT1988 in people who show early warning signs of psychosis. Researchers want to see if it changes certain markers in the body related to mental health.
This study looks at how a specific type of brain receptor (dopamine-3) works in people with schizophrenia using special brain scans (PET). Researchers want to see how these receptors behave when you are not taking antipsychotic medication, which may help guide future treatments.
This research study looks at how the brain changes in young people who are at high risk for developing psychosis. It aims to find better ways to predict and prevent psychosis by using brain imaging and thinking tests.
This early (Phase 1) study uses a special brain scan to look at synapses—the contact points between brain cells—in people with schizophrenia-related conditions. It helps researchers understand brain activity and connection patterns, which may guide future tests or treatments.
This study uses brain scans to find markers that can predict how well antipsychotic medications work in people having their first episode of psychosis. It aims to help doctors choose the right treatment earlier.
This early-phase study uses a PET brain scan (a special imaging test) to see how the brain responds in people with cocaine use disorder. It aims to better understand brain activity and whether this scan approach could help research or future treatments.
Hear when a new Clinical High Risk for Psychosis (CHR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.